image
Healthcare - Medical - Care Facilities - NASDAQ - US
$ 20.51
-2.84 %
$ 2.62 B
Market Cap
-15.42
P/E
1. INTRINSIC VALUE

This DCF valuation model was last updated on Apr, 8, 2025.

The intrinsic value of one SGRY stock under the worst case scenario is HIDDEN Compared to the current market price of 20.5 USD, Surgery Partners, Inc. is HIDDEN

This DCF valuation model was last updated on Apr, 8, 2025.

The intrinsic value of one SGRY stock under the base case scenario is HIDDEN Compared to the current market price of 20.5 USD, Surgery Partners, Inc. is HIDDEN

This DCF valuation model was last updated on Apr, 8, 2025.

The intrinsic value of one SGRY stock under the best case scenario is HIDDEN Compared to the current market price of 20.5 USD, Surgery Partners, Inc. is HIDDEN

2. FUNDAMENTAL ANALYSIS

Price Chart SGRY

image
$34.0$34.0$32.0$32.0$30.0$30.0$28.0$28.0$26.0$26.0$24.0$24.0$22.0$22.0$20.0$20.0$18.0$18.015 Oct15 OctNov '24Nov '2415 Nov15 NovDec '24Dec '2415 Dec15 DecJan '25Jan '2515 Jan15 JanFeb '25Feb '2515 Feb15 FebMar '25Mar '2515 Mar15 MarApr '25Apr '25
FINANCIALS
3.11 B REVENUE
13.52%
349 M OPERATING INCOME
6.34%
12.5 M NET INCOME
205.04%
300 M OPERATING CASH FLOW
2.14%
-488 M INVESTING CASH FLOW
-116.53%
262 M FINANCING CASH FLOW
268.81%
864 M REVENUE
12.20%
127 M OPERATING INCOME
108.70%
-46.6 M NET INCOME
-53.56%
111 M OPERATING CASH FLOW
70.86%
-112 M INVESTING CASH FLOW
-125.20%
48 M FINANCING CASH FLOW
757.53%
Balance Sheet Surgery Partners, Inc.
image
Current Assets 1.12 B
Cash & Short-Term Investments 270 M
Receivables 579 M
Other Current Assets 271 M
Non-Current Assets 6.77 B
Long-Term Investments 215 M
PP&E 1.38 B
Other Non-Current Assets 5.17 B
3.42 %7.34 %3.43 %17.54 %65.54 %Total Assets$7.9b
Current Liabilities 624 M
Accounts Payable 209 M
Short-Term Debt 101 M
Other Current Liabilities 314 M
Non-Current Liabilities 5.48 B
Long-Term Debt 292 M
Other Non-Current Liabilities 5.18 B
3.42 %5.15 %4.79 %84.98 %Total Liabilities$6.1b
EFFICIENCY
Earnings Waterfall Surgery Partners, Inc.
image
Revenue 3.11 B
Cost Of Revenue 2.37 B
Gross Profit 746 M
Operating Expenses 496 M
Operating Income 349 M
Other Expenses 336 M
Net Income 12.5 M
4b4b3b3b3b3b2b2b2b2b1b1b500m500m003b(2b)746m(496m)349m(336m)13mRevenueRevenueCost Of RevenueCost Of RevenueGross ProfitGross ProfitOperating ExpensesOperating ExpensesOperating IncomeOperating IncomeOther ExpensesOther ExpensesNet IncomeNet Income
RATIOS
23.94% GROSS MARGIN
23.94%
11.20% OPERATING MARGIN
11.20%
-5.40% NET MARGIN
-5.40%
-9.39% ROE
-9.39%
-2.13% ROA
-2.13%
0.40% ROIC
0.40%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis Surgery Partners, Inc.
image
250m250m200m200m150m150m100m100m50m50m0020162016201720172018201820192019202020202021202120222022202320232024202420252025
Net Income 12.5 M
Depreciation & Amortization 153 M
Capital Expenditures -90.4 M
Stock-Based Compensation 0
Change in Working Capital -119 M
Others 3.5 M
Free Cash Flow 210 M
3. WALL STREET ANALYSTS ESTIMATES
Wall Street Analysts Price Targets Surgery Partners, Inc.
image
Wall Street analysts predict an average 1-year price target for SGRY of $35 , with forecasts ranging from a low of $31 to a high of $40 .
SGRY Lowest Price Target Wall Street Target
31 USD 51.15%
SGRY Average Price Target Wall Street Target
35 USD 70.65%
SGRY Highest Price Target Wall Street Target
40 USD 95.03%
Price
Max Price Target
Min Price Target
Average Price Target
404035353030252520201515May '24May '24Jul '24Jul '24Aug '24Aug '24Oct '24Oct '24Nov '24Nov '2420252025Feb '25Feb '25Apr '25Apr '25Jun '25Jun '25Jul '25Jul '25Aug '25Aug '25Oct '25Oct '25Nov '25Nov '2520262026Feb '26Feb '26Apr '26Apr '26
4. DIVIDEND ANALYSIS
5. COMPETITION
slide 2 of 10
6. Ownership
Insider Ownership Surgery Partners, Inc.
image
Sold
0-3 MONTHS
3.51 M USD 7
3-6 MONTHS
0 USD 0
6-9 MONTHS
197 K USD 1
9-12 MONTHS
324 K USD 2
Bought
0 USD 0
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
7. News
Surgery Partners, Inc. (SGRY) Q4 2024 Earnings Call Transcript Surgery Partners, Inc. (NASDAQ:SGRY ) Q4 2024 Earnings Conference Call March 3, 2025 8:30 AM ET Company Participants Eric Evans - Chief Executive Officer Dave Doherty - Executive Vice President and Chief Financial Officer Conference Call Participants Brian Tanquilut - Jefferies Benjamin Rossi - JPMorgan Chase Joanna Gajuk - Bank of America A.J. Rice - Credit Suisse Tao Qiu - Macquarie Research Andrew Mok - Barclays Matthew Gillmor - KeyBanc Capital Markets Whit Mayo - SVB Leerink Sarah James - Cantor Fitzgerald Operator Greetings. seekingalpha.com - 1 month ago
Surgery Partners (SGRY) Q4 Earnings and Revenues Surpass Estimates Surgery Partners (SGRY) came out with quarterly earnings of $0.44 per share, beating the Zacks Consensus Estimate of $0.38 per share. This compares to earnings of $0.44 per share a year ago. zacks.com - 1 month ago
These 2 REITs Make Great Buys For Income Investors REITs have surged in value. But opportunities still remain for income-oriented investors. I present two REITs to buy today. seekingalpha.com - 1 month ago
Surgery Partners, Inc. Announces Fourth Quarter 2024 Earnings Release Date and Conference Call Details BRENTWOOD, Tenn., Feb. 18, 2025 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading short-stay surgical facility owner and operator, announced the Company will release its fourth quarter 2024 results before the market opens on Monday, March 3, 2025, to be followed by a conference call at 8:30 a.m. (Eastern Time). globenewswire.com - 2 months ago
Japan In The Spotlight; Blockchain In AI's Shadow As the global private equity industry took tentative steps toward recovery in 2024, Japan raced ahead. The value of private equity investment in Japan jumped nearly 41% over the prior-year total in 2024, far outpacing the 25% year-over-year gain in global private equity deal value, according to S&P Global Market Intelligence data. seekingalpha.com - 2 months ago
Surgery Partners (SGRY) Surges 21.2%: Is This an Indication of Further Gains? Surgery Partners (SGRY) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term. zacks.com - 2 months ago
Surgery Partners, Inc. Confirms Receipt of Non-Binding Acquisition Proposal from Bain Capital BRENTWOOD, Tenn., Jan. 28, 2025 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ: SGRY) (“Surgery Partners” or the “Company”), a leading short-stay surgical facility owner and operator, today announced that its Board of Directors (the “Board”) received a non-binding proposal, dated January 27, 2025, from Bain Capital Private Equity, LP (“Bain Capital”) to acquire all of the outstanding shares of Surgery Partners not already owned by Bain Capital for a cash consideration of $25.75 per share (the “Bain Capital Proposal”). Bain Capital and its affiliates own approximately 39% of the Company's outstanding common stock, based on the Schedule 13D/A filing dated January 28, 2025. globenewswire.com - 2 months ago
Bain Capital proposes to acquire remaining shares of Surgery Partners Bain Capital Private Equity has proposed to acquire the remaining shares of surgical facility operator Surgery Partners it does not already own for $25.75 apiece, a filing showed on Tuesday. reuters.com - 2 months ago
Surgery Partners, Inc. Names Laura L. Forese, MD to Board of Directors BRENTWOOD, Tenn., Jan. 13, 2025 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) (“Surgery Partners” or the “Company”) today announced that Dr. Laura L. Forese has been appointed to serve as an independent director on its Board of Directors. Dr. Forese's appointment, which is effective January 10, 2025, will increase the size of Surgery Partners' Board to eleven members. globenewswire.com - 3 months ago
Surgery Partners, Inc. (SGRY) Q3 2024 Earnings Call Transcript Surgery Partners, Inc. (NASDAQ:SGRY ) Q3 2024 Earnings Conference Call November 12, 2024 8:30 AM ET Company Participants Dave Doherty - Chief Financial Officer Wayne DeVeydt - Executive Chairman Eric Evans - Chief Executive Officer Conference Call Participants Jack Slevin - Jefferies Joanna Gajuk - Bank of America A.J. Rice - UBS Andrew Mok - Barclays Tao Qiu - Stifel Sarah James - Cantor Fitzgerald Bill Sutherland - The Benchmark Company Benjamin Rossi - JPMorgan Will Spivack - TD Cowen Operator Greetings, and welcome to the Surgery Partners Third Quarter 2024 Earnings Call. seekingalpha.com - 5 months ago
Surgery Partners (SGRY) Misses Q3 Earnings Estimates Surgery Partners (SGRY) came out with quarterly earnings of $0.19 per share, missing the Zacks Consensus Estimate of $0.25 per share. This compares to earnings of $0.19 per share a year ago. zacks.com - 5 months ago
Surgery Partners (SGRY) Earnings Expected to Grow: What to Know Ahead of Next Week's Release Surgery Partners (SGRY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations. zacks.com - 5 months ago
8. Profile Summary

Surgery Partners, Inc. SGRY

image
COUNTRY US
INDUSTRY Medical - Care Facilities
MARKET CAP $ 2.62 B
Dividend Yield 0.00%
Description Surgery Partners, Inc., through its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company operates through two segments, Surgical Facility Services and Ancillary Services. Its surgical facilities comprise ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including gastroenterology, general surgery, ophthalmology, orthopedics, and pain management. The company's surgical hospitals also provide ancillary services, such as diagnostic imaging, pharmacy, laboratory, obstetrics, oncology, physical therapy, and wound care; and ancillary services, which consist of multi-specialty physician practices, urgent care facilities, and anesthesia services. As of December 31, 2021, it owned or operated a portfolio of 126 surgical facilities, including 108 ambulatory surgical centers and 18 surgical hospitals in 31 states. Surgery Partners, Inc. was founded in 2004 and is headquartered in Brentwood, Tennessee.
Contact 310 Seven Springs Way, Brentwood, TN, 37027 https://www.surgerypartners.com
IPO Date Sept. 30, 2015
Employees 15000
Officers Ms. Danielle Burkhalter Executive Vice President & Chief Human Resources Officer Mr. Spencer Clark General Counsel & Senior Vice President Ms. Jennifer B. Baldock J.D. Executive Vice President and Chief Administrative & Development Officer Mr. David T. Doherty CPA Executive Vice President & Chief Financial Officer Mr. Neil C. Zieselman Senior Vice President of Corporate Finance & Controller Mr. Varun Gadhok Senior Vice President & Chief Information Officer Ms. Roxanne Womack Senior Vice President & Chief Compliance Officer Ms. Marissa A. Brittenham Executive Vice President & Chief Strategy Officer Mr. Wayne Scott DeVeydt Executive Chairman Mr. J. Eric Evans Chief Executive Officer & Director